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Differential expression and co-
expression gene networks reveal 
candidate biomarkers of boar taint 
in non-castrated pigs
Markus Drag  1,4, Ruta Skinkyté-Juskiené  1, Duy N. Do2, Lisette J. A. Kogelman1,3 & Haja N. 
Kadarmideen  1,4
Boar taint (BT) is an offensive odour or taste observed in pork from a proportion of non-castrated male 
pigs. Surgical castration is effective in avoiding BT, but animal welfare issues have created an incentive 
for alternatives such as genomic selection. In order to find candidate biomarkers, gene expression 
profiles were analysed from tissues of non-castrated pigs grouped by their genetic merit of BT. 
Differential expression analysis revealed substantial changes with log-transformed fold changes of liver 
and testis from −3.39 to 2.96 and −7.51 to 3.53, respectively. Co-expression network analysis revealed 
one module with a correlation of −0.27 in liver and three modules with correlations of 0.31, −0.44 and 
−0.49 in testis. Differential expression and co-expression analysis revealed candidate biomarkers with 
varying biological functions: phase I (COQ3, COX6C, CYP2J2, CYP2B6, ACOX2) and phase II metabolism 
(GSTO1, GSR, FMO3) of skatole and androstenone in liver to steroidgenesis (HSD17B7, HSD17B8, 
CYP27A1), regulation of steroidgenesis (STARD10, CYB5R3) and GnRH signalling (MAPK3, MAP2K2, 
MAP3K2) in testis. Overrepresented pathways included “Ribosome”, “Protein export” and “Oxidative 
phosphorylation” in liver and “Steroid hormone biosynthesis” and “Gap junction” in testis. Future work 
should evaluate the biomarkers in large populations to ensure their usefulness in genomic selection 
programs.
Boar taint (BT) is an offensive odour that occurs in cooked or heated pork from a proportion of non-castrated 
male pigs. Two compounds are mainly responsible for BT: skatole (3-methyl-indole) and androstenone 
(5α-androst-16-ene-3-one)1,2. Skatole is a by-product of enzymatic breakdown of L-tryptophan by bacterial 
action in the large intestine and subsequently absorbed into the blood3. Androstenone is a steroid produced in 
the testis where it is transported by blood to the salivary gland and functions as a mating pheromone4. It is syn-
thesised from pregnenolone in association with sexual maturity together with other testicular steroids, such as 
testosterone and oestrogens5,6. Due to their lipophilic properties, the compounds accumulate in the adipose tissue 
and concentrations are correlated with the level of sexual maturity at the time of slaughter7,8 and/or the inten-
sity of liver degradation9,10. A distinct relationship between androstenone and skatole exists: high concentration 
of androstenone prevents breakdown of skatole by inhibiting enzymes responsible for skatole metabolism and 
causes accumulation in adipose tissues11. Furthermore, androstenone itself is an active contributor to BT, and it 
has been proposed that elevated levels of androstenone are primary to elevated levels of skatole in the hierarchy 
of BT development12. Threshold levels for skatole and androstenone concentrations in fat considered to cause BT 
are 0.5 to 1 µg/ g for androstenone and 0.20 to 0.25 µg/g for skatole2.
Boar taint is the main factor preventing the production of non-castrated male pigs in many countries13 and 
often leads to depreciation of the carcass, even though their production is associated with a number of signifi-
cant economic advantages including increased efficiency, leaner carcasses and lower faecal and urinary nitrogen 
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losses14. Furthermore, production of non-castrated males is often viewed as advantageous in the context of animal 
welfare due to the absence of surgical castration. Indeed, this practice is often performed without anaesthesia or 
analgesia which results in pain and stress for the animal15, but the practice is justified by its alleviation of aggres-
sion and sexual activity which can result in leg fractures and skin damage16. Surgical castration is also an effective 
technique for avoiding BT, but increased attention to the animal welfare issues has led to a voluntary initiative to 
end the practice in the European Community from January 1, 201817.
In order to avoid BT in the production of non-castrated males without surgical castration, two overall solu-
tions have been proposed: (i) chemicals and/or chemotherapeutics such as immunocastration and (ii) optimised 
animal breeding programs. For the first solution, immunocastration by Improvac® (Pfizer Ltd, NY, USA) has 
been found to be an effective strategy against BT with no detrimental effects on carcass and meat quality18–23 and 
with environmental benefits such as increased or at least similar growth rates and feed conversion efficiencies 
between immunised and surgically castrated pigs24. However, the European Food Safety Authority (EFSA) has 
anticipated poor public acceptance of immunocastration25,26 due to the possible perception of a link with hor-
mone treatment and possible harmful residues24,27.
For the latter solution, genomic-based breeding programs have been proposed. As skatole and androstenone 
are moderate to highly heritable traits9,11,28–30, reduction of BT would be possible through breeding programs. 
By this strategy, breeding organisations would apply genomic selection on individuals with desirable genotypes 
that are predisposed to low genetic merit of BT compounds without the need for trait recording31. Previous work 
has indeed established low and mostly favourable genetic correlations between BT compounds and production 
traits such as the quality of meat without negatively affecting important male fertility trait32. Thus, selection of 
low genetic merit of BT can be deemed an effective and sustainable solution. By employing molecular genetic 
methods, identification of male pigs with low genetic merit of BT is possible, before they actually develop the 
condition or have their traits recorded33. However, this requires knowledge on highly predictive key genes asso-
ciated with the trait of interest. In turn, these genes can be applied as biomarkers, e.g. Mazzoni, et al.34 and Salleh, 
et al.35. Finding biomarkers with strong predictive powers for a trait can be greatly enhanced with omics tech-
nologies, such as transcriptomics36. By measuring changes in gene expression profiles, analysis of differentially 
expressed (DE) genes associated with BT has been performed in a variety of breeds and experimental designs (as 
reviewed by Zadinová, et al.37). While many studies employed microarrays to obtain gene expression profiles, a 
few employed RNA sequencing (RNA-Seq) which provides far more precise measurements of transcript expres-
sion levels and their isoforms than traditional technologies38. Another powerful analysis within transcriptomics 
is construction of co-expression networks which reveal co-expressed (CE) genes with a high connectivity (“hub 
genes”). Hub genes are often regulatory genes, with major impact on genetic networks and may affect the trait of 
interest39–41. To the authors knowledge, no studies have applied a systems biology approach36 to genetic merit of 
BT. By this approach, findings from DE and CE analyses from RNA-Seq data are integrated in order to enhance 
discriminatory power of highly associated genes, useful as candidate biomarkers within animal breeding.
The aims of this study were: (i) to detect important DE genes in gene expression profiles of liver and testis in 
male pigs associated with divergent genetic merit of BT, (ii) to build co-expression networks by application of the 
Weighted Gene Co-expression Network Analysis (WGCNA) method42 and extract important hub genes, (iii) to 
integrate results and extract candidate biomarkers associated with genetic merit of BT and evaluate their potential 
within animal breeding (Fig. 1).
Results
Genetic merit of boar taint. The animal model in this study comprised of commercial Danish Landrace 
male pigs (n = 114). The pigs were produced from sires with known genetic merit of BT assessed from estimated 
breeding values (EBVs) of skatole concentrations in fat and human nose scores (HNS). The genetic merit of 
BT was defined as the summarised EBVs calculated as the sum of EBVs of skatole and HNS obtained from the 
respective sire of each pig. In brief, EBVs are a measure of the relative genetic performance compared with a con-
temporary group of a trait and used as an industry standard in animal breeding. The full concept, definition and 
methods used to calculate EBVs are given in Bourdon and Bourbon43. Based on the distribution of summarised 
EBVs, a total of 48 pigs (16 low, 16 medium and 16 high) were selected and used in the analysis, representing 
a low, medium and high genetic merit of BT. The means of the summarised EBVs (±standard deviation) for 
each group were 0.71 (±0.19), −0.01 (±0.09) and −0.38 (±0.17) for high, medium and low genetic merit of BT, 
respectively. A list of selected animals and their EBVs are available in Supplementary file 1.
RNA sequencing of liver and testis tissue. RNA-Seq was performed on liver and testis tissue of the 
selected pigs. Post-mapping quality control revealed that a mean of 33.25 million reads throughout the 96 samples 
had been successfully mapped to the reference genome. The number of reads (±SD) aligned to genes in liver and 
testis tissue were 7.76 (±1.61) million and 7.04 million (±2.44), respectively. Quality control revealed a distribu-
tion of 50.14% exonic reads, 41.29% intergenic reads and 8.57% intronic reads in liver and 47.42% exonic reads, 
37.89% intergenic reads and 14.79% intronic reads in testis. After filtering of genes with expression levels equal to 
or fewer than five counts, the number of genes included in the differential expression and co-expression analyses 
were 10,545 for liver and 12,731 for testis, respectively.
Identification of differentially expressed genes. Differential expression analysis of liver and testis by 
contrast of high vs low genetic merit of BT from the three-group study design revealed 507 and 5,943 differentially 
expressed (DE) genes (FDR < 0.05), respectively. An additional filtering step which compared expression profiles 
for each DE gene throughout the three groups revealed that 241 and 2,315 genes were significantly (P < 0.05) 
different across groups in liver and testis, respectively. The log-transformed fold change of the DE genes in liver 
and testis ranged from −3.39 to 2.96 and −7.51 to 3.53, showing substantial gene expression differences. The top 
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significant DE genes were MORN2, AASDHPPT, SPCS3, SEC. 11 C and NDUFC1 in liver and LAMP1, TNPO1, 
TOPORS, GFPT1 and COX4I1 in testis. The top 25 most significant DE genes found in liver and testis are pre-
sented in Table 1 and Table 2, respectively. Full result tables are included in Supplementary file 2.
Gene functional enrichment analysis. Gene functional enrichment analysis revealed a total of 39 
and 421 significantly enriched (Adj. P-val. < 0.05) gene ontology (GO) terms in liver and testis, respectively 
(Supplementary file 3). Subsequent filtering of redundant GO terms by semantic similarity further reduced the 
amount in order to visually represent the most enriched terms in each tissue (Fig. 2). In liver, “Peptide meta-
bolic processes” (Adj. P-val. = 1.1 × 10−4) were the most significantly enriched GO terms of Biological Process 
(BP), “Mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)” (Adj. P-val. = 0.9 × 10−7) 
were the most significantly enriched Cellular Component (CC) terms and”Transferase activity, transferring 
one-carbon groups” (Adj. P-val. = 1.8 × 10−2) were the most significantly enriched Molecular Function (MF) 
terms (Fig. 2a). In testis, the GO terms “Organelle organization” (Adj. P-val. = 1.8 × 10−50) were the most sig-
nificantly enriched BP, “Intracellular part” (Adj. P-val. = 4.4 × 10−115) were the most significantly enriched CC 
and finally, “Transmembrane signalling receptor activity” (Adj. P-val. = 1.0 × 10−61) were the most significantly 
enriched MF (Fig. 2b). A total of 11 GO terms were found to be significantly (Adj. P-val. < 0.05) enriched in 
both tissues which comprised 5 BP and 6 CC terms. According to results obtained from each individual tissue, 
the most significantly enriched common GO terms were “Mitochondrion” (Adj. P-val. = 3.2 × 10−5), “Peptide 
metabolic process” (Adj. P-val. = 1.1 × 10−4) and “Cellular amide metabolic process” (Adj. P-val. = 1.9 × 10−4) 
in liver and “Catalytic complex” (Adj. P-val. = 1.0 × 10−25), “Transferase complex” (Adj. P-val. = 5.0 × 10−20) and 
“Ribonucleoprotein complex biogenesis” (Adj. P-val. = 1.9 × 10−5) in testis.
Gene functional enrichment analysis of a fixed number (n = 507) of the top DE genes from each tissue revealed 
the MF GO terms “Transferase activity, transferring one-carbon groups”, “S-adenosylmethionine-dependent 
methyltransferase activity”, “Cytochrome-C oxidase activity” with child GO term “Hydrogen ion transmembrane 
transporter activity” and “Peptidase activator activity” with child GO term “Cysteine-type endopeptidase reg-
ulator activity involved in apoptotic process” significantly enriched (Adj. P-val. < 0.05) in liver. Furthermore, 
“Translation factor activity, RNA binding”, “Helicase activity”, “Ubiquitin-protein transferase activity”, “ 
Figure 1. Illustration of the study design. From a total of 114 Landrace male pigs, 48 pigs were grouped 
as having low, medium and high boar taint (BT) according to estimated breeding values (EBVs) of skatole 
and human nose score of their respective sires. Each group consisted of 16 pigs. At 100 kg weight, they were 
slaughtered and two tissues were sampled. Of these, liver and testis tissues were subjected to paired-end RNA 
sequencing. These were analysed for differentially expressed (DE) genes and co-expressed (CE) genes which 
were extracted from co-expression networks by a range of statistical methods. In turn, this led to the discovery 
of candidate biomarkers for BT and BT related pathways.
www.nature.com/scientificreports/
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Lysine-acetylated histone binding”, “Peptide N-acetyltransferase activity”, “P-P-bond-hydrolysis-driven trans-
membrane transporter activity” and “NAD + binding” were significantly enriched (Adj. P-val. < 0.05) in testis. 
The MF GO terms from both tissues were visualised with the DE genes mapped to their corresponding GO terms 
and the expression levels in the “low BT” and “high BT” groups for liver (Fig. 3a) and testis (Fig. 3b).
Pathway enrichment analysis. Pathway analysis revealed six and 20 significantly enriched (Adj. 
P-val. < 0.05) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in liver and testis, respec-
tively (Supplementary file 4). The top three significantly enriched pathways found were “Ribosome” (Adj. 
P-val. = 5.0 × 10−4), “Protein export” (Adj. P-val. = 6.4 × 10−4) and “Alzheimer’s disease” (Adj. P-val. = 4.3 × 10−3) 
in liver and “Neuroactive ligand-receptor interaction” (Adj. P-val. = 1.1 × 10−9), “Cytokine-cytokine receptor 
interaction” (Adj. P-val. = 1.1 × 10−6) and “Thyroid hormone signalling pathway” (Adj. P-val. = 7.8 × 10−5) in 
testis. A selection of pathways deemed biologically interesting were visualised with their DE genes mapped to 
their corresponding pathways and the expression levels in the “low BT” and “high BT” in liver (Fig. 4a) and testis 
(Fig. 4b). These pathways were “Ribosome”, “Oxidative phosphorylation”, “Gluthathione metabolism”, “Protein 
export”, “Folate biosynthesis” and “Drug metabolism” in liver and “Taste transduction”, “GnRH signalling path-
way”, “Drug metabolism”, “Steroid hormone biosynthesis” and “Gap junction” in testis.
Co-expression network analysis. In liver, no modules were found to be significantly (P < 0.05) asso-
ciated with genetic merit of BT, but one module (lightgreen) containing 593 genes was found to have a strong 
tendency of association with genetic merit of BT (P = 0.06) with a negative correlation (module-trait relationship 
(r) = −0.27). Hence, the module was selected for additional analysis. SERPINC1, PRDX3, HSD17B8, GSTZ1 and 
NIT1 were found to be hub genes (Fig. 5a). The intramodular connectivity defined as the node degree (k) (links 
per node) of the individual hub gene ranged from 23 to 36 and module membership measure ranged from 0.77 
to 0.84. Enrichment analysis of the genes from the lightgreen module revealed “Small molecule catabolic pro-
cess”, “Lipid metabolic process” and “Cofactor metabolic process” as the top three significantly (adj. P-val. < 0.05) 
enriched BP GO terms (Fig. 5b). Due to its biological relevance, GO term “Organic hydroxyl compound meta-
bolic process” was selected for further analysis which revealed child GO terms of “Cellular hormone metabolic 
Gene Description logFCa FDRb K-W P.
MORN2 MORN repeat containing 2 −0.83 0.007 0.0043
AASDHPPT aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase −0.62 0.009 0.011
SPCS3 signal peptidase complex subunit 3 −0.64 0.009 0.073
SEC. 11 C SEC11 homolog C, signal peptidase complex subunit −0.73 0.009 0.024
NDUFC1 NADH:ubiquinone oxidoreductase subunit C1 −0.76 0.009 0.0079
ZNF181 zinc finger protein 181 −0.58 0.009 0.0012
ARL5A ADP ribosylation factor like GTPase 5A −0.66 0.009 0.0023
NEURL1 neuralized E3 ubiquitin protein ligase 1 −1.30 0.009 0.0053
EIF1AY eukaryotic translation initiation factor 1A, Y-linked −0.60 0.009 0.011
SGPP1 sphingosine-1-phosphate phosphatase 1 −0.74 0.009 0.0044
PLGRKT plasminogen receptor, C-terminal lysine transmembrane protein −0.65 0.009 0.024
SFR1 SWI5-dependent homologous recombination repair protein 1 −1.28 0.009 0.0049
ATP5H ATP synthase, H+ transporting, mitochondrial Fo complex subunit D −0.86 0.009 0.019
KBTBD3 kelch repeat and BTB (POZ) domain containing 3 −0.69 0.009 0.0068
DUS4L dihydrouridine synthase 4-like −0.59 0.009 0.02
MED21 mediator complex subunit 21 −0.62 0.009 0.015
COMMD8 COMM domain containing 8 −0.74 0.010 0.016
SNX14 sorting nexin 14 −0.61 0.010 0.058
ACTR6 ARP6 actin-related protein 6 homolog (yeast) −0.60 0.010 0.056
MOCS2 molybdenum cofactor synthesis 2 −0.79 0.010 0.039
PDCD10 programmed cell death 10 −0.62 0.010 0.018
ZBTB8OS zinc finger and BTB domain containing 8 opposite strand −0.58 0.011 0.068
METTL23 methyltransferase like 23 −0.62 0.011 0.014
NIPSNAP3B nipsnap homolog 3B (C. elegans) −0.49 0.011 0.014
IKBIP IKBKB interacting protein −1.03 0.011 0.011
Table 1. Top 25 differentially expressed (DE) genes from liver. aLogFC = the log2 transformed fold change 
obtained from the limma procedure. bFDR = the Benjamini-Hochberg (FDR) procedure adjusted P value 
obtained from the limma procedure. cK-W P. = the P value obtained from Kruskal Wallis test of expression 
profile from each gene throughout the three groups. Abbreviations: LogFC log transformed fold change, FDR 
False Discovery Rate, K-W Kruskal Wallis.
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process”, “Hormone metabolic process”, “Steroid metabolic process”, “Cholesterol metabolic process” and “Lipid 
homeostasis” (Fig. 5c).
In testis, two modules were found to be significantly (P < 0.05) associated with genetic merit of BT: darkgreen 
and tan containing 180 and 519 genes, respectively. Furthermore, the darkturquoise module was found to have 
a tendency of association with genetic merit of BT (P = 0.05). The module darkgreen containing 180 genes was 
positively correlated with the summarised EBVs (r = 0.31), whereas tan had a negative correlation (r = −0.49). 
COPZ2, RAMP2, VDAC1 and SLC25A6 were found to be hub genes in the darkgreen module (Fig. 6a) with 
intramodular connectivity ranging from 24 to 35 and module membership measure ranging from 0.34 to 0.53. 
The top three most significantly (adj. P-val. < 0.05) enriched BP GO terms attributed to darkgreen module were 
“Carboxylic acid catabolic process”, “Small molecule catabolic process” and “Sterol molecule metabolic process” 
(Fig. 6b). The GO term “Sterol metabolic process” was selected for further analysis which revealed further GO 
annotations of “Cholesterol biosynthetic process”, “Coenzyme binding”, “Flavin adenine dinucleotide binding”, 
“Oxidoreductase activity, acting on the CH-CH group of donors”, and “Oxidoreductase activity, acting on the 
CH-CH group of donors, NAD or NADP as acceptor” (Fig. 6c). Full result tables from co-expression analysis are 
included in Supplementary file 5.
Candidate biomarker selection. By combining results from differential expression analysis with 
co-expression analysis and applying a reductionist strategy, a total of 16 candidate biomarkers were detected as 
potential biomarkers: COQ3, COX6 C, GSTO1, GSR, FMO3, CYP2J2, CYP2B6 and ACOX2 in liver (Fig. 7a) and 
HSD17B7, HSD17B8, MAPK3, MAP2K2, MAP3K2, STARD10, CYB5R3 and CYP27A1 in testis (Fig. 7b). Briefly, 
the reductionist strategy comprised selection of candidate biomarkers from genes that were found as significant 
(FDR < 0.05) in the differential expression analysis and significant (P < 0.05) in additional filtering by expression 
profile comparison. Furthermore, the genes were either: (i) annotated to relevant GO terms and/or pathways and/
or (ii) part of a co-expression module associated with genetic merit of BT.
Discussion
In this study, candidate biomarkers associated with divergent genetic merit of boar taint (BT) was identified from 
RNA sequencing (RNA-Seq) of liver and testis of Danish Landrace pigs. The genetic merit of BT was defined from 
the estimated breeding values (EBVs) of skatole concentrations and human nose score (HNS) obtained from the 
sires of each pig. The HNS method has been shown to be a rapid, sensitive and cost-effective system with good 
Gene Description logFCa FDRb K-W P.
LAMP1 lysosomal-associated membrane protein 1 0.73 8.077E-06 0.015
TNPO1 transportin 1 −0.81 8.077E-06 1.20E-05
TOPORS topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase −0.56 8.077E-06 7.10E-06
GFPT1 glutamine–fructose-6-phosphate transaminase 1 −0.82 1.139E-05 0.00019
COX4I1 cytochrome c oxidase subunit IV isoform 1 0.77 1.139E-05 0.059
RLF rearranged L-myc fusion −0.70 1.139E-05 7.70E-05
C17orf62 chromosome 17 open reading frame 62 0.91 1.139E-05 1.20E-05
KIAA1109 KIAA1109 −1.24 1.139E-05 0.00063
RAB5C RAB5C, member RAS oncogene family 0.67 1.139E-05 0.008
IRGC immunity-related GTPase family, cinema 0.99 1.139E-05 0.023
LRPAP1 LDL receptor related protein associated protein 1 0.52 1.181E-05 0.015
MZT2A mitotic spindle organizing protein 2 A 0.93 1.181E-05 0.0054
ZNF3 zinc finger protein 3 −1.59 1.181E-05 0.00043
KANSL1L KAT8 regulatory NSL complex subunit 1 like −1.22 1.182E-05 0.00056
EXOC5 exocyst complex component 5 −1.05 1.302E-05 0.00043
MAF1 MAF1 homolog, negative regulator of RNA polymerase III 0.57 1.302E-05 3.00E-04
PARPBP PARP1 binding protein −1.54 1.302E-05 0.00051
HLTF helicase-like transcription factor −1.04 1.372E-05 0.00021
ATR ATR serine/threonine kinase −0.62 1.372E-05 5.50E-05
ZYG11B zyg-11 family member B, cell cycle regulator −1.19 1.372E-05 0.00077
HNRNPAB heterogeneous nuclear ribonucleoprotein A/B 0.64 1.372E-05 0.015
PFN1 profilin 1 0.62 1.372E-05 0.0052
EDF1 endothelial differentiation-related factor 1 1.45 1.372E-05 0.029
SLC25A39 solute carrier family 25 member 39 0.86 1.372E-05 0.056
CREBRF CREB3 regulatory factor −1.41 1.372E-05 0.003
Table 2. Top 25 differentially expressed (DE) genes from testis. aLogFC = the log2 transformed fold change 
obtained from the limma procedure. bFDR = the Benjamini-Hochberg (FDR) procedure adjusted P value 
obtained from the limma procedure. cK-W P. = the P value obtained from Kruskal Wallis test of expression 
profile from each gene throughout the three groups. Abbreviations: LogFC log transformed fold change, FDR 
False Discovery Rate, K-W Kruskal Wallis.
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correlations with androstenone and skatole levels and contains the ability to capture subjective variation not 
obtained by laboratory assays44. However, the HNS method is prone to some limitations that are intrinsically 
linked to using human beings as trained panellists: (i) regional differences in panels perception of BT compounds 
and training of panellists45; (ii) moderate reproducibility due to differences in human sensitivity and percep-
tion of BT even in experienced panellists46 and (iii) accuracy of panels is related to the number of panellists 
and their individual olfactory acuity47. The EBVs (the relative genetic performance compared with a contempo-
rary group43) were calculated by Genomic BLUP Animal Models48,49 and is used by breeding organisations as a 
measure of genetic merit. This is related to the advantage of EBVs which can be calculated for a large number of 
Figure 2. Bar plot of enriched gene ontology (GO) terms of (a) liver and (b) testis. Y-axis indicates the GO 
term, X-axis indicates the adjusted P-value. Abbreviations: BP Biological process, CC cellular component, MF 
molecular function.
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animals without phenotypic data via their pedigree or genomic relationship with animals having phenotypic data 
by a Best Linear Unbiased Prediction (BLUP) framework. Collecting phenotypic data of BT traits on large num-
ber of animals is also very prohibitive. As this study was concerned with animal breeding under industry settings, 
we integrated EBVs from the breeding sires with gene expression profiles of their progeny to find candidate bio-
markers associated with genetic merit of BT. Hence, biomarkers will be able to identify pigs with low genetic merit 
of BT for selection, before they develop BT and have the trait recorded which is of high relevance in practical and 
cost-effective breeding programs. The EBVs were adjusted for age (in days) and carcass weight (in kg) at slaughter. 
Thus, systematic differences in sexual maturation between pigs were accounted for in order to ensure consistent 
steroidogenic potential in the three groups, as warranted in previous research33. Gene expression profiles were not 
subjected to further correction by any covariates other than technical normalisation. Previous work found EBVs 
as a very reliable phenotype indicator50 and they have been successfully applied in gene co-expression analysis51.
A shortcoming of the current study is the lack of phenotypic data. Due to the commercial nature of the pigs, we 
did not have access to phenotypic measurements. In a previous study by Lervik, et al.50, the correlation between 
EBVs of androstenone and the androstenone phenotype was high. On the other hand, skatole has a slightly lower 
heritability than androstenone30 and we expect some disparity due to lack of correlation between EBVs and phe-
notype in the individual pig at slaughter weight (~100 kg). Thus, the lack of phenotypic data means that any dis-
parity between genetic merit and BT phenotype cannot be identified or quantified. However, we emphasise that 
the current study identifies candidate biomarkers of genetic merit of BT and the candidate biomarkers found in 
this study cannot be used directly for phenotype identification without prior validation.
Liver metabolism of xenobiotic substances is divided into two phases: phase I metabolism which comprises 
oxidation, reduction and hydroxylation steps to make the substrate more soluble in water by adding or expos-
ing a functional group and phase II sulfoconjugation which adds polar groups for increased hydrophilicity and 
excretion52,53. Related to the phase II sulfoconjougation, transferase activity was found to be highly enriched GO 
term in liver, but not in testis (Fig. 2a). Transferases are a large group of enzymes involved in transfer of specific 
functional groups from one molecule to another and previous studies have indicated their importance in catal-
ysis of phase II sulfoconjugation of 16-androstene steroids in liver and testis52,54. All eleven DE genes annotated 
to “Single-carbon transferase activity” in liver (Fig. 3a) were downregulated in high BT pigs, indicating a strong 
Figure 3. Network visualisation of molecular function gene ontology terms found in (a) liver and (b) testis 
obtained by from a fixed amount of the top 507 differentially expressed genes. Each term is represented by a 
circle whose diameter is negatively correlated with the adjusted P value (pV). Each node represents a gene where 
the expression levels are indicated in the circle where the green group (left side) represents the expression level 
in low BT group and the red group (right side) represents the expression level in high BT group.
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decrease in phase II metabolism of BT compounds. Furthermore, transferase activity was found enriched in 
both tissues which emphasises the importance of transferase-related genes of BT. Interestingly, COQ3 encodes 
an O-methyltransferase that is required for two steps in the biosynthetic pathway of coenzyme Q 10 (CoQ10). 
CoQ10 is involved in the respiratory chain and participates in aerobic cellular respiration which generates energy 
in the form of ATP55. In mammals, tissues with high energy demands, such as heart, liver and kidney, have the 
highest CoQ10 concentrations56,57. As the BT condition is dependent on the level of liver degradation, it is likely 
that the downregulated expression of COQ3 reflects insufficient metabolism. Hence, COQ3 is considered a can-
didate biomarker for BT in liver (Fig. 7a).
Important enriched MF terms in liver included “cytochrome-c oxidase activity” which comprised isoforms of 
COX6 and COX7. These genes encode subunits of cytochrome-c oxidase, the terminal enzyme of the mitochon-
drial respiratory chain catalysing the electron transfer from reduced cytochrome-c to oxygen58. Previous stud-
ies reported genes encoding cytochrome oxidases of the mitochondrial respiratory chain to be associated with 
skatole levels12,59–62. Specifically, the cytochrome subunit family COX4I1 and COX8 C encoding cytochrome-c 
oxidases were involved in regulation of skatole metabolism63,64, which was attributed to their involvement in 
the phase I oxidation reactions in liver. In this study, the cytochrome-c oxidases COX6 C, COX7AL, COX7B2 
and COX7A1 were all downregulated in the high BT pigs which may reflect the situation of deficient skatole 
metabolism in high BT pigs. Another strong indicator of the importance of cytochrome-c oxidases in the context 
of BT is the high enrichment of mitochondrial CC GO terms where the enzymes are located. Hence, COX6 C is 
considered a candidate biomarker for BT in liver (Fig. 7a). Another important MF term found enriched in liver is 
the oxidoreductases, specifically the “CH-CH oxidoreductases” which participate in the phase I metabolism of BT 
compounds and play important enzymatic roles, some which have not yet been precisely clarified65. In this study, 
the “CH-CH oxidoreductases” comprised ACAD10, ACADSB, ACOX2, CPOX and DUS4L (Supplementary file 3) 
which are commonly found in gene expression studies for BT in liver65 and testis66,67. Interestingly, all five genes 
were downregulated in the high BT pigs (Supplementary file 2), which may be attributed to the insufficient liver 
degradation of BT compounds. ACOX2 encodes a protein of the acyl-Coenzyme A oxidase family which involves 
degradation of long branched fatty acids and bile acid intermediates in peroxisomes68. The similar ACOX1 was 
previously found to be slightly upregulated in high BT pigs65. The current finding suggests a contrary expression 
pattern for ACOX2 as the gene is indeed downregulated in high BT pigs. ACOX2 is also found in the lightgreen CE 
module in liver where the gene is functionally annotated to “Steroid metabolic process” (Fig. 5c). Hence, ACOX2 
is considered a candidate biomarker for BT (Fig. 7a).
Figure 4. Network visualisation of a selection of the most biologically interesting and overrepresented 
pathways in (a) liver and (b) testis. Each pathway is represented by a circle whose diameter is negatively 
correlated with the adjusted P-value (pV) of the given term. Each node represents a gene where the expression 
levels are indicated in the circle where the green group (left side) represents the expression level in low BT group 
and the red group (right side) represents the expression level in high BT group.
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Analysis of overrepresented pathways in liver revealed a strong correlation towards active transcription 
(“Ribosome”), export of proteins (“Protein export”) and oxidation (“Oxidative phosphorylation”) (Fig. 4a). 
Analysis of the specific DE genes annotated to “Drug metabolism” revealed FMO3 and CYP2B6. Flavin-containing 
monooxygenases (FMOs) are a family of enzymes that converts lipophilic compounds into polar metabolites, 
thus decreasing their activity69. The FMOs are involved in metabolic activation or detoxification of numerous 
xenobiotics such as pesticides, drugs and carcinogens70. FMOs are regulated by sex steroid hormones and FMO3 
was found to be repressed by testosterone and upregulated by castration71. Furthermore, FMO3 was previously 
speculated to be associated with off flavour in pork72. Consistently, we found FMO3 downregulated in high BT as 
androstenone and testosterone levels are positively correlated7. Hence, FMO3 is considered a candidate biomarker 
for BT in liver (Fig. 7a). The cytochrome P450 (CYP) proteins are also monooxygenases and similar in function 
to FMOs; they are involved in drug metabolism and synthesis of cholesterol, steroids and other lipids73. In human 
and pig, 18 families of CYPs have been identified with 57 and 54 genes, respectively73. The CYPs have previously 
been reviewed as candidate genes for BT37. In the current study, ten CYPs were identified as DE genes: CYP2J2, 
CYP2B6 in liver and CYP4V2, CYP1B1, CYP2D7, CYP2R1, CYP51A1, CYP20A1, CYP26B1 and CYP27A1 in 
testis (Supplementary file 2). In liver, CYP2B6 was upregulated in the high BT group which clearly reflects its 
implication in phase I metabolism. Another member of the CYP2 family was the CYP2J2 which was found to 
be upregulated in high BT. Interestingly, previous studies showed that the CYP2B was found only to metabolise 
skatole to a low degree and to our knowledge, no data is available for CYP2J (see a review by Rasmussen and 
Zamaratskaia74). In testis, CYP27A1 was found to be strongly upregulated in high BT pigs. In porcine hepatocytes, 
CYP27A1 has been found to be active in 25-hydroxylation of the prohormone vitamin D3 and to carry out the 
27-hydroxylation of cholesterol-derived intermediates in bile acid biosynthesis75. In this context, it is likely that 
CYP27A1 is affected by the increased steroid production characterised in high BT pigs and to our knowledge, 
Figure 5. Composite visualisation of the lightgreen module in liver. (a) Network visualisation of hub genes 
in the module. Hub genes are indicated by large font and circle size; (b) Bar plot of gene ontology (GO) terms 
related to the module. Y-axis indicate the GO term, X-axis indicate the adjusted P-value and (c) analysis of genes 
related to the GO term “Organic hydroxy compound metabolic process”. Abbreviations: BP Biological process, 
CC cellular component, MF molecular function.
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we are the first to report association of the gene with BT. Hence, CYP2J2, CYP2B6 and CYP27A1 are considered 
candidate biomarkers for BT in liver and testis, respectively (Fig. 7).
GSTO1 and GSR are part of “Glutathione metabolism” and “Drug metabolism” pathways and participate in the 
phase II metabolism. GSTO1 encodes a member of the glutathione S-transferases (GSTs) that are known for their 
role in catalysis of conjugation reactions in endogenous substances, haeme, fatty acids, xenobiotics and products 
of oxidative processes76. In context of BT, GSTO2 has been speculated to be involved in excretion of skatole from 
the porcine body77. We found GSTO1 to be clearly downregulated in high BT pigs (Fig. 4a), which could explain 
the BT condition observed by decreased excretion of skatole. The finding is consistent with previous gene expres-
sion studies in liver65 and testis66. Due to its implication in relevant pathways and clear expression pattern, GSTO1 
could be considered a candidate biomarker (Fig. 7a). GSR encodes a glutathione reductase enzyme that catalyses 
the reduction of glutathione disulphide to glutathione, an important antioxidant and critical for the cell to resist 
oxidative stress and to maintain its reducing environment78. The expression of GSR is probably related to liver 
degradation capacity as GSR exhibited a clear pattern of downregulation in high BT pigs. Hence, GSR is consid-
ered a candidate biomarker in liver (Fig. 7a). However, the precise relationship between GSR and BT compounds 
should be subject to further research.
Analysis of DE genes from testis revealed “Transmembrane signalling receptor activity” to be a highly enriched 
MF GO term. This may reflect the fact that steroid hormone biosynthesis is a highly active function in the testis 
of high BT pigs, as previous research has found a high genetic correlation between androstenone (plasma and fat) 
and sex steroids in Duroc and Landrace pigs79. Activation and regulation of steroid hormone biosynthesis requires 
a high level of cellular communication observed by enrichment of the MF GO terms “Poly(A) RNA binding” and 
“Enzyme binding” which reflects the high pathway activity. Furthermore, the CC GO terms such as “Intracellular 
part” and “Nuclear part” revealed that most processes are located in the intracellular part or nuclear part where 
transcription and translation are undertaken in the cell (Fig. 2b). The BP term “Organelle organization” was 
highly enriched which probably reflects high activity of transcription and protein metabolic processes. When a 
Figure 6. Composite visualisation of the darkgreen module in testis. (a) Network visualisation of hub genes 
in the module. Hub genes are indicated by large font and circle size; (b) Bar plot of gene ontology (GO) terms 
related to the module. Y-axis indicates the GO term, X-axis indicates the adjusted P-value and (c) analysis of 
genes related to the GO term “Steroid metabolic process”. Abbreviations: BP Biological process, CC cellular 
component, MF molecular function.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7: 12205  | DOI:10.1038/s41598-017-11928-0
fixed number of top DE genes between tissues were subjected to MF GO term enrichment analysis, “Translation 
factor activity, RNA binding” had four upregulated genes in high BT pigs which probably is attributed to the high 
level of steroidgenesis. Interestingly, genes associated with the term “Ubiquitin-protein transferase activity” were 
almost exclusively downregulated in the high BT pigs. This family of transferases is responsible for the transfer 
of ubiquitin from one protein to another which can signal the degradation of the protein by the proteasome. The 
downregulation of the associated genes implies a markedly less regulated steroidgenesis which probably results 
in overproduction of steroid hormones in testis. This hypothesis is supported by the significant overrepresenta-
tion of the pathway “Steroid hormone biosynthesis” which comprises the 17 β-hydroxysteroid dehydrogenase 
(HSD) genes HSD17B7 and HSD17B8 (Fig. 4b). The 17β-HSD encode enzymes that are part of the last catalysis 
step in the formation of androgens and estrogens80 and the various types provide specific cell types with the 
mechanisms to regulate intracellular androgens and/or estrogens81. The importance of the HSD family in relation 
to BT compounds has been well documented in both RNA-Seq and microarray studies and both HSD17B2 and 
HSD17B4 have previously been suggested as biomarkers for reduced BT37,66,77,82. We also found the HSD17B7 and 
HSD17B8 to be highly upregulated in the high BT pigs. HSD17B7 is involved in biosynthesis of cholesterol83 and 
Figure 7. Selected candidate biomarkers with their associated box plot from (a) liver and (b) testis. Y-axis 
indicates normalised expression levels. X-axis indicates low, medium and high boar taint (BT) groups. Finally, 
the P-value (p) indicates the result from a separate Kruskal-Wallis test on expression levels of the candidate 
biomarker throughout the three BT groups.
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sex steroids84 and regulates bioavailability of both androgens and estrogens, yet interestingly, previous work has 
confirmed that the HSD17B7 is not the key enzyme responsible for androstenone and testosterone metabolism 
in porcine hepatocyte85. However, we found the HSD17B7 upregulated in testis and not liver, which consequently 
justifies the proposition of it being a candidate biomarker in testis (Fig. 7b). The HSD17B8 is involved in regu-
lation of concentrations of biologically active estrogens and androgens86. Recently, the protein encoded by the 
HSD17B8 was identified as a major interaction partner in gene networks of pigs with divergent androstenone 
levels. The major function of the protein was hypothesised to be testosterone inactivation87. The testicular testos-
terone concentrations were positively correlated with androstenone concentrations due to active testosterone syn-
thesis which could also imply active androstenone synthesis87. However, we found that HSD17B8 was upregulated 
in testis from high BT pigs which is contrary to the hypothesis that HSD17B8 inactivates testosterone synthesis. 
We suggest that the gene plays an important role in BT and is considered a candidate biomarker, but further 
research should clarify its exact role in regulation of BT compounds (Fig. 7b).
The selection of pathways of biological interest included the “Drug metabolism”, “Estrogen signalling path-
way” and “GnRH signalling pathway” (Fig. 4b). In “GnRH signalling pathway”, genes had both up- or downreg-
ulation patterns, but mostly downregulated. MAPK3 and MAP2K2 were upregulated whereas MAP3K2 were 
downregulated in high BT pigs, respectively (Fig. 4b). The MAPK pathway encodes protein kinases which have 
been shown to modulate numerous male reproductive functions such as spermatogenesis, sperm maturation 
and activation and other functions of the germ cells88. Interestingly, MAPK3, MAP2K2 and MAP3K2 were also 
a part of the “Estrogen signalling pathway” (Supplementary file 4). The “Estrogen signalling pathway” was sig-
nificantly overrepresented, which is probably due to secretion of large amounts of estrogen from the testis89. 
Estrogen concentrations have been found to be correlated with androstenone in adipose tissue90,91. The roles of 
the MAPK pathway in variation of BT has recently been shown in a gene expression study on Duroc boars92. The 
authors found that upregulation of MAPK coincided with pubertal increase in androstenone and testosterone 
production92 as the upregulation was observed several weeks earlier than complex morphological restructuring 
of testis into reproductive tissue. Furthermore, proteins encoded by MAPK may regulate the Steroidogenic Acute 
Regulatory protein (STAR) (a cholesterol traffic regulator) and have a complex interaction with steroidgenesis 
(see review by Manna and Stocco93). Interestingly, STARD10, which may play a metabolic role in sperm matu-
ration and lipid transport93, was found upregulated in testis (Supplementary file 2) and may have other localised 
functions such as enrichment of lipids in milk in the mammary glands94. Previous works have documented the 
role of a subfamily of STAR in BT in testis, especially STARD6 and STAR66,92. To our knowledge this is the first 
time a relationship between STARD10 and BT has been reported and the association warrants further investiga-
tion of the role of STARD10 in BT. Due to the complexity of MAPK in BT and the warrant for further research of 
these genes, MAPK3, MAP2K2, MAP3K2 and STARD10 are considered candidate biomarkers (Fig. 7b).
Co-expression analysis in liver revealed the lightgreen module to be associated and slightly downregulated 
with the summarised EBVs. Among the five hubs genes (HSD17B8, GSTZ1, SERPINC1, PRDX3 and NIT1), 
HSD17B8 was also DE in testis and selected as a candidate biomarker. Furthermore, HSD17B8 was co-expressed 
with CYB5A. Expression levels of CYB5A has previously been linked to androstenone levels94. Hence, the finding 
of HSD17B8 as a hub gene strengthens the hypothesis of a regulatory role in androstenone synthesis. GSTZ1 was 
found as a hub gene in the lightgreen module and as a DE gene in liver which encodes a member of the GSTs95. 
Other hub genes included SERPINC1 (Fig. 5a) which encode a gene that inhibits thrombin as well as other acti-
vated serine proteases of the coagulation system and regulates the blood coagulation cascade96. Members of the 
SERPIN family have previously been associated with skatole metabolism in liver77 and it is very likely that the 
hub genes are all related through various mechanisms in the clearing of skatole and/or androstenone from the 
liver either directly or indirectly through regulation or activation of other genes and/or pathways. Interestingly, 
SERPINC1 was co-expressed with HSD17B13 which is not exactly clear as 17β-HSD catalyses biosynthesis of 
androgens and estrogens but the finding warrants further research into the association of SERPINC1 and BT. The 
darkgreen module was significantly enriched for the MF GO term “Steroid metabolic process” which comprised 
SULT1B1 and CYP7A1. Downregulation of CYP7A1 has been speculated to increase androstenone levels through 
reduced fat catabolism82 which is consistent with the current study where the gene was downregulated in high 
BT pigs. Considering the finding of CYP7A1 as co-expressed in liver, additional research should be focused on its 
role in BT. SULT1B1 encodes a member of the sulfotransferases which catalyse the sulphate conjugation of steroid 
hormones, neurotransmitters, drugs and xenobiotic compounds97 and previous work established them as key 
enzymes involved in the testicular and hepatic metabolism of androstenone66. The closely related SULT1A1 were 
found to be involved in phase II metabolism of skatole98 and a mutation in the gene is thought to be responsible 
for skatole accumulation99 which has prompted researchers to consider it a candidate biomarker for BT37. Indeed, 
the sulfotransferases seem important in the metabolism of BT compounds as a negative correlation between accu-
mulation of androstenone and SULT2A1 in which low activity of SULT2A1 was found in animals with high con-
centrations of androstenone100. Similar results were found in a study performed on Duroc, Norwegian Landrace 
and Yorkshire67 which is also consistent with the findings in the current study where SULT1B1 was downregulated 
in high BT pigs. The finding of SULT1B1 as a co-expressed gene reflects a possible regulatory association and 
warrants further research on its precise role in BT. In the current study, only SULT4A1 was found as a DE gene in 
testis and upregulated in high BT pigs but it did not pass additional filtering (Supplementary file 2).
In testis, the significantly associated darkgreen module contained genes significantly enriched for “Carboxylic 
acid catabolic process”, “Small molecule catabolic process” and “Sterol molecule metabolic process” (Fig. 6b). 
Further analysis of the “Sterol metabolic process” term revealed that several genes overlapped with “Cholesterol 
biosynthetic process” (Fig. 6c). Interestingly, the previously selected candidate biomarker HSD17B7 was part of 
the darkgreen module and the finding of HSD17B7 as a co-expressed gene may point to some kind of regulatory 
function in BT. However, this is in contrast to previous research where HSD17B7 was excluded as a key enzyme 
responsible for androstenone and testosterone metabolism in porcine liver cells85. Another important enriched 
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gene in the module was CYB5R3 which encodes a cytochrome b5 reductase101. The subfamily CYB5 has been 
found particular important in androstenone biosynthesis and expression levels and a mutation in CYB5A was 
speculated to decrease androstenone levels94,102. From its role as a reductase, CYB5R3 is a modulator of the activ-
ity of CYB5A103. Interestingly, work on nuclear receptor transactivation found that CYB5R1 probably increased 
levels of 16-androstene steroids but ambiguous results were found for CYB5R3104. In the current study, CYB5R1 
was also found as a DE gene in testis (Supplementary file 3) but did not pass additional filtering. Due to strong 
upregulation and co-expression of CYB5R3 in high BT pigs, we consider the gene as a candidate biomarker in 
testis (Fig. 7b).
In this study, the candidate biomarkers were genes with functions within phase I (COQ3, COX6 C, CYP2J2, 
CYP2B6, ACOX2) and phase II metabolism (GSTO1, GSR, FMO3) of skatole and androstenone in liver to 
steroidgenesis (HSD17B7, HSD17B8, CYP27A1), regulation of steroidgenesis (STARD10, CYB5R3) and GnRH 
signalling (MAPK3, MAP2K2, MAP3K2) in testis. For comparison, a recently published review by Zadinová, 
et al.37 summarised genes currently believed to be controlling levels of androstenone (CYP11A1, CYP17A, 
CYP21A2, CYB5A, LHB, HSD17B7), androstenone metabolism (HSD3B, SULT2A1, SULT2B1, TEAD3), phase I 
skatole metabolism (CYP2A6, CYP2E1, CYB5A) and phase II skatole metabolism (SULT1A1). Other important 
genes were FMO372, GSTO277, COX4I164, MAPK1479, STARD692 and ACOX177. Thus, a high level of consistency 
is evident between known gene families involved in BT and the selection of candidate biomarkers in this study. 
Importantly, our study presents two new genes (COQ3, GSR) and novel gene members and isoforms of BT which 
is probably attributed to the use of deep sequencing of ~33 mio reads per sample to register even small fluctua-
tions in gene expression. Some candidate biomarkers probably share similar functions with known genes of BT 
such as the case of HSD3B and HSD17B91 or may be involved in regulation of known candidate biomarkers such 
as CYB5R3 that regulates CYB5A103. Furthermore, co-expression network analysis provided valuable insight into 
the complexity of both DE and non-DE genes and their functions in BT such as CYP7A1 and SULT1B1 and ena-
bled discovery of hub genes with a possible regulatory association such as HSD17B8 and SERPINC1 co-expressed 
with CYB5A and HSD17B13¸ respectively.
Future work should focus on the validation of the detected biomarkers at the population-wise level as well 
as in other breeds to develop a sensitive and specific industry-targeted test for optimised genomic-based animal 
breeding to reduce BT. Gene expression data should be combined with genotypes to find expression quantitative 
trait loci (eQTLs) of BT and/or further utilise the power of the RNA-Seq data with additional analysis of splic-
ing events, polymorphisms and different isoforms of transcripts105 of the candidate biomarkers proposed in this 
study.
Methods
A complete overview of the experimental design is presented in Fig. 1.
Animal model. Male Landrace pigs (n = 114) were housed at the commercial testing station Bøgildgård in 
Denmark (N 56°27′52.60′′ W 9°38′62.97′′) operated by the Pig Research Centre, SEGES (Copenhagen, Denmark) 
and raised with ad libitum feed and water supply. The pigs were produced from sires with known genetic merit of 
boar taint (BT) assessed from estimated breeding values (EBVs) of skatole concentrations and human nose score 
(HNS). To account for both traits, the genetic merit of BT was defined as the sum of the EBVs of skatole concen-
tration and HNS obtained from the respective sire of each pig and denoted as the summarised EBV following 
equation (1):
Summarised EBV Skatole EBV Human nose score EBV (1)ij ij ij= +
where the summarised EBVi is the sum of the EBV for skatole concentration in fat and the EBV for HNS for the 
individual pig i obtained from its respective sire j. All EBVs were collected from the Danish pig breeding database 
(Pig Research Centre, SEGES, Copenhagen, Denmark). The raw values for skatole concentrations were obtained 
from measurements on carcass fat samples by a calorimetric method106. HNS were collected by a standardised 
method107. The EBVs (the relative genetic performance compared with a contemporary group) were calculated by 
Genomic BLUP Animal Models48,49. The EBVs were corrected for age (days) and weight (kg) in order to account 
for systematic differences in sexual maturation and to obtain full steroidogenic potential33 in the three groups.
Subsequently, the animals were grouped as low, medium or high genetic merit of BT, according to the summa-
rised EBVs. A total of 48 pigs out of the 114 pigs were selected for analysis from each of the three groups as high, 
medium and low genetic merit of BT (Supplementary file 1). The selection of pigs was based on the most extreme 
values within each of the low and high groups, and the closest values to the mean in the medium group. To 
account for any pedigree effects, the maximum amount of relatedness allowed between pigs but within sire groups 
were only half-siblings. However, the sires themselves were not related as far as we could find in the dataset.
Tissue collection and preparation. Pigs were slaughtered at a weight of ~100 kg at a commercial slaugh-
terhouse (Danish Crown, Herning, Denmark). Slaughter was performed by submersion into CO2 until uncon-
sciousness ensued followed by exsanguination. Following slaughter, the liver was extracted from the carcass and 
150 mg of tissue were retrieved by punch biopsy and immediately immersed into 1.5 ml RNAlater (QIAGEN, 
Hilden, Germany) in 2 ml Eppendorf tubes (Eppendorf, Hamburg, Germany). The carcasses were kept in a cold 
room at 4 °C for approximately 1.5 h before 150 mg testis tissue were retrieved by punch biopsy and immersed 
into 1.5 ml RNAlater (QIAGEN). All samples (n = 96) were stored at −20 °C for 14 days until RNA extraction and 
sequencing at a commercial facility (AROS A/S, Aarhus, Denmark).
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RNA extraction and sequencing. Total RNA was extracted from the 96 samples by RNeasy Mini Kit 
(QIAGEN) following instructions of the manufacturer. Concentration of RNA was measured by Nanodrop® 
2000 (ThermoScientific, Massachusetts, USA). The quality of the RNA was measured with a Bioanalyzer (Agilent, 
California, USA) to ensure an RNA integrity number (RIN) of at least 6; otherwise, the samples were discarded. 
For samples with an RIN values of 7 or above, the sequencing libraries were prepared using the TruSeq stranded 
mRNA (Illumina, San Diego, USA) kit following instructions of the manufacturer. Samples with RIN values 
from 6 to 7 were therefore prepared using the TruSeq total stranded RNA (Illumina) kit following instructions of 
the manufacturer. In both protocols, 400 ng of total RNA were used as input and fragmentation was performed 
following instructions of the manufacturer, but with an incubation step of 1 min at 94 °C protocol to produce 
libraries that are compatible with sequencing on a paired-end 100 base pair flow cell (PE-100bp FC, Illumina, 
San Diego, USA). Libraries were subjected to quality control with respect to size profile by test on an Agilent 
DNA 1000 (Agilent, California, USA) and library concentration by KAPA quantitative PCR (qPCR) kit and 
three independent 106-fold dilutions of libraries following instructions of the manufacturer (Kapa Biosystems, 
Massachusetts, USA). The samples were sequenced with an Illumina HiSeq. 2500 (Illumina, San Diego, USA) 
which amounted to a theoretical 40 million reads per sample.
Quality control and gene counting. Data from sequencing machine were converted from base calls into 
FastQ-files by CASAVA®-software (Illumina, San Diego, USA). Quality control (QC) of RNA-Seq reads was con-
ducted with FastQC108. Reads were trimmed for known Illumina TruSeq adapter sequences using the programme 
CutAdapt109. Poor reads were trimmed by Trimmomatic110 using default parameters. The trimmed reads were 
then mapped to the Sus scrofa reference genome (10.2, version 79) obtained from Ensembl111 by the STAR aligner 
using default parameters112. Post-mapping QC was performed with Qualimap113. The mapped reads were counted 
to each gene by HTSeq count using default parameters114. All subsequent statistical analysis were performed in R 
version 3.1.0115. Only genes with a mean count of more than five were included in the gene count matrices. Due 
to relatively poor annotation of the Sus scrofa genome, Ensembl identifiers were translated into their human ort-
hologous gene symbols by the R package biomaRt116,117, using the Homo sapiens reference genome (h38, version 
84, Ensembl).
Differential expression analysis. Normalisation of gene counts was performed by voom 
variance-stabilization function with sample quality weights118 implemented in the R package limma. Differentially 
expressed (DE) genes were detected using the R package limma119. Briefly, limma fits a linear model to each gene 
using the function lmFit following equation (2):
γ β ε= +BT (2)ij j BT ij,
where γij is the measured expression level of gene j for individual pig i, j BT,β  is the estimated regression coefficient 
calculated by regression of the gene expression value of the ith individual pig categorised to its genetic merit of BT 
group (“low”, “medium” or “high”) for the jth gene and εij is the error component. By using the function eBayes in 
limma, the moderated t-test statistics for differences in the variance of gene expression of a gene across replicates 
were calculated and subjected to multiple testing correction of the P values by the Benjamini-Hochberg proce-
dure120 which resulted in a false discovery rate (FDR) and the logarithm-transformed fold change for each gene. 
Genes were categorised as differentially expressed genes when FDR was below 0.05 and were found by contrasting 
“high BT vs low BT” groups from a design matrix that included all three groups. Additional filtering was per-
formed by comparison of expression profiles of the individual DE gene throughout the three groups by a 
Kruskal-Wallis test. Gene functional enrichment analysis was performed with the Cytoscape121 plug-in ClueGO 
version 2.2.5122. By providing DE genes and genes attributed to co-expression modules with significant associa-
tion to the summarised EBVs, ClueGO performed overrepresentation test and visualisation for gene ontology 
(GO) terms and KEGG pathways using default parameters. Test results were subjected to multiple testing correc-
tion of the P values by Bonferroni correction. For semantic filtering of redundant GO terms, the online tool 
REVIGO123 was used. As the BT condition involves numerous enzymatic functions and for the sake of simplicity, 
the most interesting molecular function (MF) GO terms from a fixed number (n = 507) of top DE genes from 
each tissue to make analysis consistent. Similar DE analyses based on 3 or more categories and treatment groups 
with similar sample sizes / biological replicates and RNA-Seq data in animals have been applied for various con-
ditions including Mazzoni, et al.34 for cattle reproduction and Salleh, et al.35 for cattle feed efficiency.
Co-expression analysis. In order to identify strongly co-expressed (CE) genes (“hub genes”) which may 
have regulatory functions and/or major impact on the trait, we employed a co-expression analysis approach for 
each tissue which has previously been successfully employed by our group40. Scale-free undirected co-expression 
networks were built using the R package WGCNA42,124 and modules with significant association (P < 0.05) to 
genetic merit of BT were detected and analysed. The genetic merit of BT was inputted as the high, medium and 
low groups defined from the summarised EBVs as described in the animal model section. The co-expression anal-
yses was performed independently for liver and testis by the following procedure: An adjacency matrix compris-
ing Pearson’s correlations between expression levels of genes was created from the 7,500 most highly expressed 
genes from the tissue in question which satisfied the requirements of both acceptable computational time and bio-
logical meaningfulness. Subsequently, the matrix was raised by a power (β) of 10 in each tissue which was found 
to be an appropriate value by the function pickSoftThreshold() to reach a scale-free topology index (R2) of at least 
0.90. The topological overlap measure (TOM), which assesses the degree of shared neighbours between pairs of 
genes, was calculated from the adjacency matrix and used to build a gene dendrogram which detects modules 
and assigns colour by the DynamicTreeCut algorithm125, using a minimum of 30 genes per module. The module 
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eigengene, the first principal component of each module, represents the expression value of each module and was 
used to detect biologically relevant modules. The module-trait relationship was calculated as the Pearson’s corre-
lation between the module eigengene and the traits of interest. Modules significantly (P < 0.05) associated with 
genetic merit of BT were exported for topological analysis and visualisation in the software VisANT126. An arbi-
trarily chosen subset of 150 gene pairs with the highest TOM within the selected modules was selected and hub 
genes were defined as genes with highest intramodular connectivity. The intramodular connectivity was assessed 
by a chosen topological analysis of the module: genes with a node degree distribution (k) (links per node) of ≥12 
were assigned as hub genes for the specific tissue.
Candidate biomarkers. Selection of candidate biomarkers for each tissue was made by applying a reduc-
tionist strategy of genes that had significant (FDR < 0.05) differential expression and significant (P < 0.05) 
difference in expression profiles by a Kruskal-Wallis test throughout the three groups and were either: (i) anno-
tated to relevant GO terms and/or pathways and/or (ii) part of a co-expression module related to a summarised 
EBVs of skatole and HNS. Each chosen candidate biomarker was visualised on a box plot with the P value of the 
Kruskal-Wallis test.
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